Please login to the form below

Not currently logged in
Email:
Password:

Sanofi-aventis strengthens in biotechnology

Sanofi-aventis has invested almost €200m to convert its pharmaceutical production site at Vitry-sur-Seine in France to produce monoclonal antibodies

As part of its move to enhance its presence in the biotechnology field, sanofi-aventis has invested almost €200m to convert its pharmaceutical production site at Vitry-sur-Seine in France to produce monoclonal antibodies from 2012.

The factory will be the site for 'Biolaunch', a project that will promote the first cell culture biotechnology platform of the group. 

"Monoclonal antibodies will open the way to a new generation of better targeted and more effective treatments with fewer side effects," declared chief executive officer, Chris Viehbacher. "This project, which gathers and mobilises the best expertise both inside and outside the company, is an illustration of the ongoing transforming programme within sanofi-aventis."

The change of use is part of a long-term approach to develop sanofi-aventis' investments in the biotechnological sector, augmenting the group's current production of vaccines, insulins and heparins.  

This project is a core part of the conversion plan for the site, which aims to turn it into a comprehensive biotechnology platform for research, development and production. Furthermore, the facility will be made available to other companies to use for development or production, enabling sanofi-aventis to benefit from partnerships that could result in new products.

The Biolaunch project is linked with a major training programme in new biotech business activities, which comprises modules in both theory and practice.

6th May 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

The Challenges Of UX In Healthcare: Technology To Change Lives
Blue Latitude Health Director and Head of Customer Experience Elisa Del Galdo explores the latest digital healthcare trends and reveals the innovations changing the sector today....
It’s all about patient outcomes… right?
Lessons from history: a design thinking perspective...
Emma Walmsley 2
30 Women Leaders in UK Healthcare (part 3)
Continuing our special feature on Women Leaders in UK Healthcare...

Infographics